BNR Burning Rock Biotech Limited
Healthcare$14.31-1.38%ClosedMarket Cap: $15.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.19
P/S
0.19
EV/EBITDA
7.44
DCF Value
$-703.58
FCF Yield
-32.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.7%
Operating Margin
-10.2%
Net Margin
-10.3%
ROE
-10.0%
ROA
-6.7%
ROIC
-9.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $126.3M | 78.0% | $-12.0M | $-15.4M | $— | — |
| FY null | $539.6M | 74.7% | $-54.8M | $-55.3M | $— | — |
| Q3 null | $131.6M | 75.1% | $-16.1M | $-16.8M | $— | — |
| Q2 null | $148.6M | 72.8% | $-11.5M | $-9.7M | $— | — |
| Q1 null | $133.1M | 73.2% | $-15.2M | $-13.5M | $— | — |
| Q4 null | $126.0M | 71.0% | $-81.9M | $-81.3M | $— | — |
| FY null | $515.8M | 70.3% | $-357.6M | $-346.6M | $— | — |
| Q3 null | $128.6M | 71.4% | $-38.6M | $-35.7M | $— | — |
| Q2 null | $135.5M | 70.4% | $-111.2M | $-108.0M | $— | — |
| Q1 null | $125.6M | 68.2% | $-125.8M | $-121.5M | $— | — |
| Q4 2023 | $121.1M | 64.5% | $-166.3M | $-162.2M | $-158.40 | — |
| FY null | $537.4M | 67.6% | $-669.3M | $-653.7M | $— | — |